{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:25:34Z","timestamp":1787145934310,"version":"build-2736575974"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic thromboembolic pulmonary hypertension (CTEPH) is traditionally regarded as a late complication of unresolved acute pulmonary embolism. However, this paradigm is challenged by several observations: up to half of patients lack a documented embolic history, distal or microvascular disease is common, and marked geographic differences in treatment strategies exist. While pulmonary endarterectomy (PEA) predominates in Western centers, Japanese programs have advanced balloon pulmonary angioplasty (BPA), particularly for distal disease. These discrepancies suggest that CTEPH represents a biologically heterogeneous condition rather than a post-embolic entity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and conceptual framework<\/jats:title>\n                    <jats:p>We developed an etiology-oriented framework integrating pathogenic mechanisms, vascular lesion distribution, and therapeutic strategies. Using Virchow\u2019s triad as a structural lens, dominant disease drivers were mapped to distinct phenotypes within a thrombo-vasculopathic spectrum.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five mechanistic phenotypes are proposed: (1) thromboembolism-related (Type Ia), characterized by unresolved embolic obstruction and proximal disease; (2) thrombophilia-associated (Type Ib), driven by systemic hypercoagulability; (3) inflammation- or immune-mediated (Type Ic), associated with endothelial injury and vascular remodeling; (4) structural pulmonary arteriopathy\u2013associated (Type II), in which intrinsic arterial abnormalities precede thrombosis; and (5) idiopathic (Type III), without identifiable cause. These phenotypes form a continuum defined by the relative contributions of thrombotic obstruction and intrinsic vascular remodeling. Within this framework, PEA aligns with proximal disease, whereas BPA and medical therapy correspond to distal vasculopathic phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CTEPH should be reconsidered as a heterogeneous thrombo-vasculopathic syndrome. An etiology-based framework linking pathobiology, anatomy, and treatment may help explain global practice variation and support phenotype-guided management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1910552","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:46:22Z","timestamp":1787143582000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic thromboembolic pulmonary hypertension: towards an etiology-oriented conceptual framework"],"prefix":"10.3389","volume":"13","author":[{"given":"Masayuki","family":"Nishiyama","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, Kansai Medical University","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Kansai Medical University","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakana","family":"Teranaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kansai Medical University Medical Center","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Naruko","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kansai Medical University Medical Center","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaaki","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Kansai Medical University","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry","volume":"124","author":"Pepke-Zaba","year":"2011","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1513\/pats.200605-113lr","article-title":"Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension","volume":"3","author":"Gali\u00e8","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e70213","DOI":"10.1002\/pul2.70213","article-title":"Why is pulmonary endarterectomy underused in Japan? Epidemiology, genetics, and a practical operability framework","volume":"15","author":"Nishiyama","year":"2025","journal-title":"Pulm Circ"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"00850-02020","DOI":"10.1183\/23120541.00850-2020","article-title":"Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH registry","volume":"7","author":"Guth","year":"2021","journal-title":"ERJ Open Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.125.016172","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a nationwide prospective multicenter registry in Japan (J-BPA)","volume":"18","author":"Ogo","year":"2025","journal-title":"Circ: Cardiovasc Interv"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/biomedicines12010046","article-title":"Chronic thromboembolic pulmonary hypertension: a review of the multifaceted pathobiology","volume":"12","author":"Ghani","year":"2023","journal-title":"Biomedicine"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1086\/686011","article-title":"Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension","volume":"6","author":"Matthews","year":"2016","journal-title":"Pulm Circ"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2141.2008.07323.x","article-title":"Virchow and his triad: a question of attribution","volume":"143","author":"Bagot","year":"2008","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1016\/j.jacc.2013.10.024","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"62","author":"Kim","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1161\/CIRCULATIONAHA.114.009309","article-title":"Update on chronic thromboembolic pulmonary hypertension","volume":"130","author":"Lang","year":"2014","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2967\/jnumed.106.039438","article-title":"Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension","volume":"48","author":"Tunariu","year":"2007","journal-title":"J Nucl Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"821466","DOI":"10.3389\/fpsyt.2022.821466","article-title":"Prevalence of mental disorders in patients with chronic thromboembolic pulmonary hypertension","volume":"13","author":"Dering","year":"2022","journal-title":"Front Psych"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review","volume":"164","author":"Gomes","year":"2004","journal-title":"Arch Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ccm.2018.04.007","article-title":"Pregnancy and pulmonary embolism","volume":"39","author":"Dado","year":"2018","journal-title":"Clin Chest Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12959-025-00719-7","article-title":"Cancer-associated venous thromboembolism: a comprehensive review","volume":"23","author":"Wan","year":"2025","journal-title":"Thrombosis J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.115.019470","article-title":"Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom national cohort","volume":"133","author":"Cannon","year":"2016","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.athoracsur.2012.04.004","article-title":"Pulmonary endarterectomy: recent changes in a single institution\u2019s experience of more than 2,700 patients","volume":"94","author":"Madani","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"ref19","first-page":"1","author":"Ebrahimi","year":"2023"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11748-022-01872-w","article-title":"Long-term outcomes of combined pulmonary endarterectomy and additional balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension","volume":"71","author":"Nishiyama","year":"2023","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1183\/09059180.00009111","article-title":"Risk factors for chronic thromboembolic pulmonary hypertension","volume":"21","author":"Kim","year":"2012","journal-title":"Eur Respir Rev"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1160\/TH03-02-0067","article-title":"High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension","volume":"90","author":"Bonderman","year":"2003","journal-title":"Thromb Haemost"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1183\/09031936.00049312","article-title":"Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding","volume":"41","author":"Lang","year":"2013","journal-title":"Eur Respir J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.healun.2021.10.016","article-title":"Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: risk factors and management","volume":"41","author":"Rosen","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/qjmed\/hcx236","article-title":"Chronic thromboembolic pulmonary hypertension and homocysteinaemia","volume":"111","author":"Low","year":"2018","journal-title":"QJM: Int J Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1183\/09031936.04.00042304","article-title":"Association of clinical features with HLA in chronic pulmonary thromboembolism","volume":"25","author":"Tanabe","year":"2005","journal-title":"Eur Respir J"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e12276","DOI":"10.1002\/pul2.12276","article-title":"Connective tissue disease-associated pulmonary hypertension: a comprehensive review","volume":"13","author":"Khangoora","year":"2023","journal-title":"Pulm Circ"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1183\/13993003.00962-2015","article-title":"Inflammation in chronic thromboembolic pulmonary hypertension: accomplice or bystander in altered angiogenesis?","volume":"46","author":"Hassoun","year":"2015","journal-title":"Eur Respir J"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"L951","DOI":"10.1152\/ajplung.00043.2018","article-title":"Pulmonary microvascular remodeling in chronic thrombo-embolic pulmonary hypertension","volume":"315","author":"Stam","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/ATVBAHA.107.156000","article-title":"Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension","volume":"28","author":"Bonderman","year":"2008","journal-title":"ATVB"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.21037\/acs-2021-pte-10","article-title":"Chronic thromboembolic pulmonary hypertension: the magic of pathophysiology","volume":"11","author":"Simonneau","year":"2022","journal-title":"Ann Cardiothorac Surg"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2002828","DOI":"10.1183\/13993003.02828-2020","article-title":"ERS statement on chronic thromboembolic pulmonary hypertension","volume":"57","author":"Delcroix","year":"2021","journal-title":"Eur Respir J"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2300763","DOI":"10.1183\/13993003.00763-2023","article-title":"Adult-onset idiopathic peripheral pulmonary artery stenosis","volume":"62","author":"Tamura","year":"2023","journal-title":"Eur Respir J"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/j.chest.2015.09.017","article-title":"Familial chronic thromboembolic pulmonary hypertension","volume":"149","author":"Desmarais","year":"2016","journal-title":"Chest"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.chest.2018.10.004","article-title":"Chronic thromboembolic pulmonary hypertension cases cluster in families","volume":"155","author":"Dodson","year":"2019","journal-title":"Chest"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1164\/rccm.202307-1236OC","article-title":"Shared and distinct genomics of chronic thromboembolic pulmonary hypertension and pulmonary embolism","volume":"209","author":"Liley","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11748-013-0323-4","article-title":"Recent advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension including Japanese experiences","volume":"62","author":"Ogino","year":"2014","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jtcvs.2016.02.062","article-title":"Operability assessment in CTEPH: lessons from the CHEST-1 study","volume":"152","author":"Jenkins","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-2600(23)00264-3","article-title":"Treatment of pulmonary arterial hypertension: recent progress and a look to the future","volume":"11","author":"Humbert","year":"2023","journal-title":"Lancet Respir Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.healun.2019.04.006","article-title":"Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension","volume":"38","author":"Taniguchi","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12890-017-0563-7","article-title":"Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study","volume":"17","author":"McLaughlin","year":"2017","journal-title":"BMC Pulm Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jtcvs.2019.01.019","article-title":"Chronic thromboembolic pulmonary hypertension in Austria and Japan","volume":"158","author":"Chausheva","year":"2019","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1910552\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:46:23Z","timestamp":1787143583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1910552\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":42,"alternative-id":["10.3389\/fmed.2026.1910552"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1910552","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1910552"}}